Mark cuban cost plus drug company (mccpdc) intends to generate a chemistry, manufacturing, and controls (CMC) data package suitable for an FDA abbreviated new drug application (anda).

Active Definitive Contract Awarded Last action

Contract number
W911SR26CA011
Awardee
Awarding agency
Obligated
$1,393,259

Award facts

Contract value 100% obligated
$1,393,259.04 Current and potential, with all options
Completion date 26% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Dallas, TX 75226, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $1,393,259

About this award

The Department of the Army's Joint PEO Chemical and Biological Defense awarded a $1.393 million definitive contract to Mark Cuban Cost Plus Drug Company, PBC for generation of a chemistry, manufacturing, and controls (CMC) data package suitable for FDA Abbreviated New Drug Application submission on April 13, 2026, under a total small business set-aside.

Performance is at Dallas, TX, with an ultimate completion date of April 12, 2028. The contract is firm fixed price. The awardee operates as a pharmaceutical manufacturer focused on process development and CMC data generation aligned with FDA regulatory standards, with no subcontract footprint on this engagement.

Quick answers

Who was awarded contract W911SR26CA011?

W911SR26CA011 was awarded to Mark Cuban Cost Plus Drug Company, PBC by ACC Aberdeen Proving Ground (Army Contracting Command) on April 13, 2026.

How much is contract W911SR26CA011 worth?

The government has obligated $1,393,259 on W911SR26CA011.

Which agency awarded contract W911SR26CA011?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR26CA011, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR26CA011 competed?

The extent of competition for W911SR26CA011 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award